Lonza Group AG's (VTX:LONN) Share Price Matching Investor Opinion
May 22
Swiss (SMI) Clinical Research and Equipment Industry Analysis
UpdatedMay 26, 2024
DataAggregated Company Financials
Companies7
- 7D-2.5%
- 3M10.5%
- 1Y-7.0%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.5%, driven by a pullback from Lonza Group of 2.6%. However, the industry is down 7.0% over the past year. Looking forward, earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Swiss Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 27 May 2024 | CHF54.7b | CHF10.3b | CHF1.0b | 45.2x | 54.6x | 5.3x |
| Wed, 24 Apr 2024 | CHF55.2b | CHF10.3b | CHF1.0b | 44x | 55.1x | 5.4x |
| Fri, 22 Mar 2024 | CHF56.8b | CHF10.2b | CHF1.0b | 46.1x | 56.6x | 5.5x |
| Sun, 18 Feb 2024 | CHF49.9b | CHF10.2b | CHF1.0b | 45.9x | 49x | 4.9x |
| Tue, 16 Jan 2024 | CHF42.5b | CHF9.8b | CHF1.5b | 31.9x | 28.4x | 4.3x |
| Thu, 14 Dec 2023 | CHF39.1b | CHF9.8b | CHF1.5b | 30.2x | 26.2x | 4x |
| Sat, 11 Nov 2023 | CHF39.6b | CHF9.8b | CHF1.5b | 27.5x | 26.5x | 4x |
| Mon, 09 Oct 2023 | CHF47.0b | CHF9.8b | CHF1.5b | 31.9x | 31.5x | 4.8x |
| Wed, 06 Sep 2023 | CHF53.3b | CHF9.8b | CHF1.5b | 36.9x | 35.7x | 5.5x |
| Fri, 04 Aug 2023 | CHF52.4b | CHF9.8b | CHF1.5b | 35.2x | 33.9x | 5.4x |
| Sun, 02 Jul 2023 | CHF55.6b | CHF9.7b | CHF1.6b | 36.2x | 34x | 5.7x |
| Tue, 30 May 2023 | CHF60.0b | CHF9.7b | CHF1.6b | 37.6x | 36.7x | 6.2x |
| Thu, 27 Apr 2023 | CHF58.3b | CHF9.7b | CHF1.6b | 41.2x | 35.7x | 6x |
| Sat, 25 Mar 2023 | CHF55.6b | CHF9.7b | CHF1.7b | 40.3x | 33.6x | 5.8x |
| Mon, 20 Feb 2023 | CHF58.1b | CHF9.6b | CHF1.6b | 33.9x | 35.5x | 6.1x |
| Wed, 18 Jan 2023 | CHF53.6b | CHF9.2b | CHF1.3b | 40.7x | 40.4x | 5.8x |
| Fri, 16 Dec 2022 | CHF50.7b | CHF9.2b | CHF1.3b | 37.4x | 38.2x | 5.5x |
| Sun, 13 Nov 2022 | CHF55.7b | CHF9.2b | CHF1.3b | 42.7x | 41.9x | 6.1x |
| Tue, 11 Oct 2022 | CHF50.2b | CHF9.2b | CHF1.3b | 39.6x | 38.8x | 5.5x |
| Thu, 08 Sep 2022 | CHF52.9b | CHF9.2b | CHF1.3b | 41.9x | 40.9x | 5.8x |
| Sat, 06 Aug 2022 | CHF56.2b | CHF8.9b | CHF1.3b | 34.8x | 42.9x | 6.3x |
| Mon, 04 Jul 2022 | CHF53.4b | CHF8.5b | CHF1.1b | 43.4x | 49.5x | 6.3x |
| Wed, 01 Jun 2022 | CHF59.0b | CHF8.5b | CHF1.1b | 48.4x | 54.7x | 6.9x |
| Fri, 29 Apr 2022 | CHF60.1b | CHF8.5b | CHF1.1b | 55.4x | 55.7x | 7.1x |
| Sun, 27 Mar 2022 | CHF67.4b | CHF8.3b | CHF1.1b | 48.7x | 62.4x | 8.1x |
| Tue, 22 Feb 2022 | CHF62.9b | CHF8.0b | CHF1.1b | 49.5x | 59x | 7.9x |
| Thu, 20 Jan 2022 | CHF70.3b | CHF7.4b | CHF929.2m | 72.4x | 75.7x | 9.5x |
| Sat, 18 Dec 2021 | CHF80.0b | CHF7.4b | CHF918.1m | 92.7x | 87.1x | 10.9x |
| Mon, 15 Nov 2021 | CHF79.5b | CHF7.4b | CHF918.8m | 72.2x | 86.6x | 10.8x |
| Wed, 13 Oct 2021 | CHF76.4b | CHF7.4b | CHF919.7m | 73.5x | 83.1x | 10.4x |
| Fri, 10 Sep 2021 | CHF82.8b | CHF7.4b | CHF920.8m | 85.4x | 89.9x | 11.2x |
| Sun, 08 Aug 2021 | CHF74.3b | CHF7.4b | CHF920.8m | 61.5x | 80.7x | 10.1x |
Price to Earnings Ratio
63.5x
Current Industry PE
- Investors are optimistic on the Swiss Life Sciences Tools and Services industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 54.6x which is higher than its 3-year average PE of 50.9x.
- The 3-year average PS ratio of 6.8x is higher than the industry's current PS ratio of 5.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 13% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does Swiss Clinical Research and Equipment compare with similar industries?
| CH Market | -0.60% | |
| Healthcare | -1.52% | |
| Life Sciences | -2.51% | |
| Clinical Research and Equipment | -2.51% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SKAN SKAN Group | CHF81.00 | 2.4% +CHF42.7m | 2.7% | PE69.2x |
